Clinical Benefit and Health-Related Quality of Life Assessment in Patients Treated with Cisplatin/S-1 Versus Cisplatin/5-FU: Secondary End Point Results From the First-Line Advanced Gastric Cancer Study (FLAGS)

György Bodoky, Max E. Scheulen, Fernando Rivera, Jacek Jassem, Alfredo Carrato, Vladimir Moiseyenko, Ihor Vynnychenko, Jana Prausová, Jean Luc Van Laethem, Stefano Cascinu, Jaffer A. Ajani

Research output: Contribution to journal › Article › peer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical Benefit and Health-Related Quality of Life Assessment in Patients Treated with Cisplatin/S-1 Versus Cisplatin/5-FU: Secondary End Point Results From the First-Line Advanced Gastric Cancer Study (FLAGS)'. Together they form a unique fingerprint.

Medicine & Life Sciences